查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589124

連續皮下胰島素輸注市場：按產品類型、患者類型、最終用戶分類 - 全球預測 2025-2030

Continuous Subcutaneous Insulin Infusion Market by Product (Patch Pumps, Tethered Pumps), Patient Type (Type 1 Diabetes, Type 2 Diabetes), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年連續皮下胰島素輸注市值為27.2億美元，預計到2024年將達到30.5億美元，複合年成長率為12.16%，預計到2030年將達到60.8億美元。

連續皮下胰島素輸注 (CSII) 使用胰島素幫浦精確注射胰島素，主要用於治療第 1 型糖尿病。 CSII 可改善血糖控制，並提供每日多次注射的有效替代方案。 CSII 的需求是更好地模擬胰臟功能並提高患者的依從性和生活品質。 CSII的適用範圍不僅限於第1型糖尿病，也擴大到包括部分第二型糖尿病患者、妊娠期妊娠糖尿病、兒科患者。它還支援各種最終用戶，從醫院和診所到家庭護理環境。市場成長是由技術進步、糖尿病人口增加、對先進糖尿病解決方案認知的提高以及支持性報銷政策所推動的。最新的潛在機會在於將人工智慧和物聯網整合到胰島素幫浦中，以促進即時血糖監測和預測分析。企業可以透過投資智慧泵研發以及與數位健康平台建立策略夥伴關係關係來抓住這些機會。然而，高昂的設備成本、維護成本和潛在的技術故障都是挑戰。缺乏精通設備管理的專業人員進一步阻礙了採用。安全標準和核准時限方面也存在監管瓶頸。技術創新的機會包括開發具有成本效益且易於使用的幫浦、增強數位醫療設備的網路安全措施以及閉合迴路胰島素輸送系統的進步。鼓勵患者社群的參與式設計方法為未滿足的需求提供可行的見解，並為客製化創新鋪平道路。 CSII市場是一個由少數主要企業主導的動態競爭格局，要求品牌專注於強大的產品差異化和策略聯盟。隨著醫療保健個人化程度的提高，市場將專注於根據每位患者的生活方式和需求量身定做的胰島素輸送解決方案。

主要市場統計
基準年[2023] 27.2億美元
預測年份 [2024] 30.5億美元
預測年份 [2030] 60.8億美元
複合年成長率（%） 12.16%

市場動態：快速發展的持續性皮下胰島素輸注市場的關鍵市場洞察

供需的動態交互作用正在改變持續皮下胰島素輸注市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球糖尿病患者數量不斷增加
    • 人們對先進胰島素輸送設備的認知不斷增強
    • 全球與糖尿病相關的醫療保健支出增加
  • 市場限制因素
    • 設備高成本
  • 市場機會
    • 人工智慧和物聯網等新技術進步
    • 市場參與企業發布的產品數量持續增加
  • 市場挑戰
    • 可能的風險，如糖尿病酮酸症和低血糖

波特五力：駕馭連續皮下胰島素輸注市場的策略工具

波特的五力架構是了解連續皮下胰島素輸注市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解持續皮下胰島素輸注市場的外部影響

外部宏觀環境因素在塑造連續皮下胰島素輸注市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解連續皮下胰島素注射市場的競爭格局

對連續皮下胰島素輸注市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣連續皮下胰島素輸注市場供應商的績效評估

FPNV定位矩陣是評估持續皮下胰島素輸注市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃連續皮下胰島素輸注市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，連續皮下胰島素輸注市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的糖尿病患者不斷增加
      • 人們對先進胰島素輸送設備的認知不斷增強
      • 全球與糖尿病相關的醫療費用增加
    • 抑制因素
      • 設備成本高
    • 機會
      • 人工智慧和物聯網等新技術的進步
      • 市場參與企業推出的產品數量持續增加
    • 任務
      • 可能的風險，如糖尿病酮酸症和低血糖
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章連續皮下胰島素輸注市場：依產品

  • 貼片幫浦
    • 基礎知識
    • 基礎治療和Bolus治療
    • 攤位
  • 繫繩幫浦
    • 電池
    • 胰島素儲液器和藥筒
    • 胰島素套插入裝置

第7章依病患類型分類的連續皮下胰島素輸注市場

  • 1型糖尿病
  • 2型糖尿病

第8章連續皮下胰島素輸注市場：依最終用戶分類

  • 居家護理
  • 醫院
  • 實驗室

第9章美洲連續皮下胰島素輸注市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太連續皮下胰島素輸注市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲連續皮下胰島素輸注市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Bigfoot Biomedical, Inc.
  • CeQur Corporation
  • Fresenius SE & Co. KGaA
  • MannKind Corporation
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Sanofi SA
  • Shinmyung Mediyes CO., LTD.
  • Smiths Group PLC
  • SOOIL Developments Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • Ypsomed AG
Product Code: MRR-A339DAEFA756

The Continuous Subcutaneous Insulin Infusion Market was valued at USD 2.72 billion in 2023, expected to reach USD 3.05 billion in 2024, and is projected to grow at a CAGR of 12.16%, to USD 6.08 billion by 2030.

Continuous Subcutaneous Insulin Infusion (CSII) involves using insulin pumps to deliver precise doses of insulin necessary for managing diabetes, primarily Type 1. It enhances glycemic control, offering a viable alternative to multiple daily injections. The necessity of CSII arises from its ability to better mimic pancreatic functioning, fostering improved compliance and quality of life among patients. The application extends beyond Type 1 diabetes to some Type 2 patients, gestational diabetes during pregnancy, and challenging pediatric populations. It caters to diverse end-users from hospitals and clinics to home care settings. Market growth is driven by technological advancements, an increasing diabetic population, growing awareness of advanced diabetic solutions, and supportive reimbursement policies. The latest potential opportunities lie in integrating AI and IoT with insulin pumps, facilitating real-time glucose monitoring and predictive analytics. Companies can grasp these opportunities by investing in R&D for smart pumps and by forming strategic partnerships with digital health platforms. However, high device costs, maintenance expenses, and potential technical malfunctions pose challenges. A lack of skilled professionals for device management further hinders widespread adoption. There are also regulatory bottlenecks concerning safety standards and approval timelines. Best opportunities for innovation include developing cost-effective, user-friendly pumps, enhancing cybersecurity measures for digital health devices, and advancing closed-loop insulin delivery systems. Encouraging participatory design approaches within patient communities can provide actionable insights into unmet needs, paving the way for tailored innovations. The CSII market is dynamic, with a competitive landscape spearheaded by a few dominant players, necessitating brands to focus on robust product differentiation and strategic alliances. As personalization in healthcare rises, the market will likely emphasize customized insulin delivery solutions that align with individual patient lifestyles and needs.

KEY MARKET STATISTICS
Base Year [2023] USD 2.72 billion
Estimated Year [2024] USD 3.05 billion
Forecast Year [2030] USD 6.08 billion
CAGR (%) 12.16%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Continuous Subcutaneous Insulin Infusion Market

The Continuous Subcutaneous Insulin Infusion Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of diabetes patients across the world
    • Growing awareness of advanced insulin delivery devices
    • Rising healthcare expenditure pertinent to diabetes globally
  • Market Restraints
    • High cost of devices
  • Market Opportunities
    • Emerging technological advancements such as AI and IoT
    • Ongoing rise in the number of product launches by market players
  • Market Challenges
    • Possible risks such as diabetic ketoacidosis and hypoglycemia

Porter's Five Forces: A Strategic Tool for Navigating the Continuous Subcutaneous Insulin Infusion Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Continuous Subcutaneous Insulin Infusion Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Continuous Subcutaneous Insulin Infusion Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Continuous Subcutaneous Insulin Infusion Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Continuous Subcutaneous Insulin Infusion Market

A detailed market share analysis in the Continuous Subcutaneous Insulin Infusion Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Continuous Subcutaneous Insulin Infusion Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Continuous Subcutaneous Insulin Infusion Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Continuous Subcutaneous Insulin Infusion Market

A strategic analysis of the Continuous Subcutaneous Insulin Infusion Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Continuous Subcutaneous Insulin Infusion Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Becton, Dickinson and Company, Bigfoot Biomedical, Inc., CeQur Corporation, Fresenius SE & Co. KGaA, MannKind Corporation, Medtronic PLC, MicroPort Scientific Corporation, Nipro Corporation, Sanofi S.A., Shinmyung Mediyes CO., LTD., Smiths Group PLC, SOOIL Developments Co., Ltd., Tandem Diabetes Care, Inc., and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Continuous Subcutaneous Insulin Infusion Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Patch Pumps and Tethered Pumps. The Patch Pumps is further studied across Basal, Basal & Bolus, and Bous. The Tethered Pumps is further studied across Battery, Insulin Reservoir & Cartridges, and Insulin Set Insertion Devices.
  • Based on Patient Type, market is studied across Type 1 Diabetes and Type 2 Diabetes.
  • Based on End-user, market is studied across Homecare, Hospitals, and Laboratory.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of diabetes patients across the world
      • 5.1.1.2. Growing awareness of advanced insulin delivery devices
      • 5.1.1.3. Rising healthcare expenditure pertinent to diabetes globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technological advancements such as AI and IoT
      • 5.1.3.2. Ongoing rise in the number of product launches by market players
    • 5.1.4. Challenges
      • 5.1.4.1. Possible risks such as diabetic ketoacidosis and hypoglycemia
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Continuous Subcutaneous Insulin Infusion Market, by Product

  • 6.1. Introduction
  • 6.2. Patch Pumps
    • 6.2.1. Basal
    • 6.2.2. Basal & Bolus
    • 6.2.3. Bous
  • 6.3. Tethered Pumps
    • 6.3.1. Battery
    • 6.3.2. Insulin Reservoir & Cartridges
    • 6.3.3. Insulin Set Insertion Devices

7. Continuous Subcutaneous Insulin Infusion Market, by Patient Type

  • 7.1. Introduction
  • 7.2. Type 1 Diabetes
  • 7.3. Type 2 Diabetes

8. Continuous Subcutaneous Insulin Infusion Market, by End-user

  • 8.1. Introduction
  • 8.2. Homecare
  • 8.3. Hospitals
  • 8.4. Laboratory

9. Americas Continuous Subcutaneous Insulin Infusion Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Continuous Subcutaneous Insulin Infusion Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Continuous Subcutaneous Insulin Infusion Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun Melsungen AG
  • 2. Becton, Dickinson and Company
  • 3. Bigfoot Biomedical, Inc.
  • 4. CeQur Corporation
  • 5. Fresenius SE & Co. KGaA
  • 6. MannKind Corporation
  • 7. Medtronic PLC
  • 8. MicroPort Scientific Corporation
  • 9. Nipro Corporation
  • 10. Sanofi S.A.
  • 11. Shinmyung Mediyes CO., LTD.
  • 12. Smiths Group PLC
  • 13. SOOIL Developments Co., Ltd.
  • 14. Tandem Diabetes Care, Inc.
  • 15. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET RESEARCH PROCESS
  • FIGURE 2. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL & BOLUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BATTERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN RESERVOIR & CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN SET INSERTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, FPNV POSITIONING MATRIX, 2023